La Crosse virus: a scoping review of the global evidence
Sign Up to like & getrecommendations! Published in 2018 at "Epidemiology and Infection"
DOI: 10.1017/s0950268818003096
Abstract: Abstract Urbanisation and climate change are altering the pattern of California serogroup viruses in North America. As La Crosse virus (LACV) is the most pathogenic of the California serogroup, it is important to identify changes… read more here.
Keywords: scoping review; evidence; epidemiology; crosse virus ... See more keywords
Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons.
Sign Up to like & getrecommendations! Published in 2021 at "Nature microbiology"
DOI: 10.1038/s41564-021-00968-y
Abstract: La Crosse virus (LACV) is a mosquito-borne orthobunyavirus that causes approximately 60 to 80 hospitalized pediatric encephalitis cases in the United States yearly. The primary treatment for most viral encephalitis, including LACV, is palliative care,… read more here.
Keywords: rottlerin; crosse virus; encephalitis; virus induced ... See more keywords
Investigation of Acute Flaccid Paralysis Reported with La Crosse Virus Infection, Ohio, USA, 2008–2014
Sign Up to like & getrecommendations! Published in 2017 at "Emerging Infectious Diseases"
DOI: 10.3201/eid2312.170944
Abstract: Infection with La Crosse virus can cause meningoencephalitis, but it is not known to cause acute flaccid paralysis (AFP). During 2008–2014, nine confirmed or probable La Crosse virus disease cases with possible AFP were reported… read more here.
Keywords: ohio usa; 2008 2014; acute flaccid; flaccid paralysis ... See more keywords